New study checks if drug zilucoplan seeps into breast milk

NCT ID NCT06961747

First seen Apr 05, 2026 · Last updated Jun 12, 2026 · Updated 13 times

Summary

This study looks at how much of the drug zilucoplan and its breakdown products end up in the breast milk of healthy women who are breastfeeding. Fifteen women who are at least 6 weeks postpartum and already planning to stop breastfeeding will receive daily injections of zilucoplan. Researchers will measure drug levels in milk samples to estimate how much a nursing baby might be exposed to.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UP0137 1

    RECRUITING

    Salt Lake City, Utah, 84124, United States

  • UP0137 2

    RECRUITING

    San Antonio, Texas, 78209, United States

Conditions

Explore the condition pages connected to this study.